These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38171083)

  • 1. The role of insulinoma-associated protein 1 in predicting the progression and prognosis of human olfactory neuroblastoma in China.
    Yang Y; Yue C; Li Y; Piao Y
    Pathol Res Pract; 2024 Jan; 253():155040. PubMed ID: 38171083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytological diagnosis of olfactory neuroblastoma at metastatic sites, with emphasis on role of insulinoma-associated protein 1 immunocytochemistry.
    Roy D; Sriram S; Kakkar A; Kumar R; Kaur K; Jain D; Sharma A; Thakar A
    Diagn Cytopathol; 2023 Feb; 51(2):146-152. PubMed ID: 36369994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulinoma-associated protein 1 is a prognostic biomarker in pulmonary high-grade neuroendocrine carcinoma.
    Minami K; Jimbo N; Tanaka Y; Ogawa H; Hokka D; Nishio W; Yoshimura M; Itoh T; Maniwa Y
    J Surg Oncol; 2020 Aug; 122(2):243-253. PubMed ID: 32346887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
    Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
    Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade.
    Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
    Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears.
    Hou T; Gan Q; Joseph CT; Sun X; Gong Y
    Cancer Cytopathol; 2020 Oct; 128(10):725-732. PubMed ID: 32573984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and the molecular biomarkers of olfactory neuroblastoma.
    Peng X; Liu Y; Peng X; Wang Z; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
    Pathol Res Pract; 2018 Aug; 214(8):1123-1129. PubMed ID: 29921494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases.
    Kuji S; Watanabe R; Sato Y; Iwata T; Hirashima Y; Takekuma M; Ito I; Abe M; Nagashio R; Omae K; Aoki D; Kameya T
    Gynecol Oncol; 2017 Feb; 144(2):384-390. PubMed ID: 27908529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment modalities and outcomes of olfactory neuroblastoma.
    Song CM; Won TB; Lee CH; Kim DY; Rhee CS
    Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
    Li X; Liu HG; Xie XJ; Han YD; Li M
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value and non-neuroendocrine role of INSM1 in small cell lung cancer.
    Xu X; Wang G; Duan Y; Huo Z
    Pathol Res Pract; 2022 Jan; 229():153693. PubMed ID: 34826740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of microvessel density and its correlation with clinicopathological features in human olfactory neuroblastoma.
    Wu L; An J; Liu H
    Clin Neuropathol; 2022; 41(3):114-121. PubMed ID: 35142285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulinoma-associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound-guided fine-needle aspiration cytology: An analysis of 14 patients.
    Takase Y; Naito Y; Okabe Y; Ishida Y; Yamaguchi T; Abe H; Murata K; Ito T; Tanigawa M; Kawahara A; Yano H; Akiba J
    Cytopathology; 2019 Mar; 30(2):194-200. PubMed ID: 30290028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors.
    Kim D; Viswanathan K; Goyal A; Rao R
    Cancer Cytopathol; 2020 Apr; 128(4):269-277. PubMed ID: 31977134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
    Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N; Ishikawa Y
    Am J Surg Pathol; 2020 Jun; 44(6):757-764. PubMed ID: 32118626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases.
    Leblebici C; Yeni B; Savli TC; Aydın Ö; Güneş P; Cinel L; Şimşek BÇ; Yıldız P; Tuncel D; Kayahan S
    Ann Diagn Pathol; 2019 Jun; 40():53-58. PubMed ID: 31031215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival impact of postoperative radiotherapy in patients with olfactory neuroblastoma: 513 cases from the SEER database.
    Duo GS; Feng JL; Zhang ZY; Wang LJ
    Cancer Radiother; 2022 Sep; 26(5):663-669. PubMed ID: 35249817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinoma-associated protein 1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreaticobiliary tracts.
    González I; Lu HC; Sninsky J; Yang C; Bishnupuri K; Dieckgraefe B; Cao D; Chatterjee D
    Histopathology; 2019 Oct; 75(4):568-577. PubMed ID: 31077609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
    Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.